Almirall
| Company type | Sociedad Anónima |
|---|---|
| BMAD: ALM | |
| ISIN | ES0157097017 |
| Founded | 1944 |
| Founder | Antonio Gallardo Carreras |
| Headquarters | |
Area served | International |
| Products | Ebglyss, Ilumetri, Wynzora, Klisyri, Seysara, Ebastel, Monodox, Acticlate, Almogran, Tesavel & Efficib, Solaraze, Airtal, Decoderm, Cordran, Almax, Parapres, Balneum, Sativex, Cleboril, Monovo, Actikerall. |
| Revenue | €898.8 million (2023) |
| €33.5 million (2022) | |
| Total assets | €2.302 billion (2022) |
Number of employees | 1,904 (2023) |
| Subsidiaries | Arax Co., Ltd. (Japan) |
| Website | www |
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944.
In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology.
With approximately 1,904 employees (2023), it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA.